Barrow Hanley Mewhinney & Strauss LLC Invests $45.81 Million in Ralliant Corporation $RAL

Barrow Hanley Mewhinney & Strauss LLC acquired a new stake in Ralliant Corporation (NYSE:RAL) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 1,047,576 shares of the company’s stock, valued at approximately $45,810,000. Barrow Hanley Mewhinney & Strauss LLC owned about 0.93% of Ralliant as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. lifted its stake in Ralliant by 10.7% during the third quarter. Vanguard Group Inc. now owns 14,589,423 shares of the company’s stock worth $637,995,000 after purchasing an additional 1,415,327 shares during the last quarter. Dodge & Cox acquired a new stake in shares of Ralliant during the second quarter worth $523,571,000. Viking Global Investors LP acquired a new stake in shares of Ralliant during the second quarter worth $257,200,000. State Street Corp bought a new position in shares of Ralliant in the 2nd quarter worth about $213,096,000. Finally, Flossbach Von Storch SE boosted its holdings in shares of Ralliant by 1.7% in the 3rd quarter. Flossbach Von Storch SE now owns 4,152,866 shares of the company’s stock valued at $181,605,000 after buying an additional 67,963 shares during the period.

Ralliant Price Performance

NYSE RAL opened at $44.62 on Wednesday. Ralliant Corporation has a 12 month low of $37.27 and a 12 month high of $57.02. The firm has a market capitalization of $4.99 billion and a PE ratio of 22.76. The company’s 50 day simple moving average is $48.68 and its 200 day simple moving average is $46.72. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.84 and a quick ratio of 0.58.

Ralliant (NYSE:RAL) last released its earnings results on Wednesday, February 4th. The company reported $0.69 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.67 by $0.02. The firm had revenue of $554.60 million for the quarter, compared to analyst estimates of $543.04 million. The firm’s quarterly revenue was up 1.2% compared to the same quarter last year. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 23rd. Shareholders of record on Monday, March 9th will be issued a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a yield of 0.4%. The ex-dividend date is Monday, March 9th. Ralliant’s payout ratio is presently 10.20%.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on RAL. Zacks Research cut shares of Ralliant from a “hold” rating to a “strong sell” rating in a report on Monday, February 9th. Truist Financial reduced their price objective on Ralliant from $62.00 to $49.00 and set a “buy” rating for the company in a research report on Friday, February 6th. Citigroup lowered their price objective on Ralliant from $61.00 to $51.00 and set a “buy” rating for the company in a research note on Friday, February 6th. Barclays dropped their target price on Ralliant from $60.00 to $52.00 and set an “overweight” rating on the stock in a research report on Monday, February 9th. Finally, Vertical Research upgraded Ralliant from a “hold” rating to a “buy” rating and set a $45.00 target price on the stock in a research note on Friday, February 6th. Seven research analysts have rated the stock with a Buy rating, three have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $50.50.

Insider Activity at Ralliant

In other news, SVP Karen M. Bick sold 2,530 shares of the company’s stock in a transaction dated Thursday, March 5th. The stock was sold at an average price of $46.50, for a total value of $117,645.00. Following the transaction, the senior vice president owned 42,652 shares in the company, valued at $1,983,318. This represents a 5.60% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Kate Mitchell bought 2,350 shares of the business’s stock in a transaction on Tuesday, February 10th. The stock was bought at an average price of $42.48 per share, with a total value of $99,828.00. Following the transaction, the director owned 8,411 shares in the company, valued at approximately $357,299.28. This represents a 38.77% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last ninety days, insiders bought 8,145 shares of company stock valued at $332,233.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.